v3.26.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balances, at Beginning of period at Dec. 31, 2023 $ 1,040 $ 406,925 $ (175,798) $ 232,167
Balances, at Beginning of period, Shares at Dec. 31, 2023       103,961,670
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense   13,083   $ 13,083
Vesting of restricted stock units 4 (4)    
Vesting of restricted stock units, shares       418,260
Issuance of common stock under employee stock purchase plan 1 458   $ 459
Issuance of common stock under employee stock purchase plan, shares       140,046
Exercise of stock options 12 1,585   $ 1,597
Exercise of stock options, shares       1,191,117
Net loss     (41,055) $ (41,055)
Balances, at end of period at Dec. 31, 2024 1,057 422,047 (216,853) $ 206,251
Balances, at end of period, Shares at Dec. 31, 2024       105,711,093
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense   9,213   $ 9,213
Vesting of restricted stock units 6 (6)    
Vesting of restricted stock units, shares       609,460
Issuance of common stock under employee stock purchase plan 1 223   $ 224
Issuance of common stock under employee stock purchase plan, shares       130,646
Exercise of stock options 4 428   $ 432
Exercise of stock options, shares       338,419
Net loss     (44,630) $ (44,630)
Balances, at end of period at Dec. 31, 2025 $ 1,068 $ 431,905 $ (261,483) $ 171,490
Balances, at end of period, Shares at Dec. 31, 2025       106,789,618